Repligen
RGEN
167.22
-7.64
-4.37%
Repligen
US · RGEN
#1445 by market cap
Listed 1970
167.22
-7.64
-4.37%
Live - 5344 symbols - heartbeat 204s ago
· 2026-10-08 08:13
Pre-market
165.69
-0.91%
After-hours
167.22
0.00%
Overnight
166.83
-0.23%
- Market cap
- 10.62B
- P/E (TTM)i
- 229.07
- P/Bi
- 5.03
- EPSi
- 0.86
- Div yieldi
- 0.00%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on RGEN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 123.12% -0.21pp
- Institutions
- 561
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund96.72%
Hedge Fund13.51%
Private Company5.65%
Public Company3.53%
Government Pension Fund1.62%
Sovereign Wealth Fund1.02%
VC/PE Fund0.47%
Family Office/Trust0.34%
Individual/Insider0.32%
Top holders as of 2026-06-30
BlackRock
9.54% · 5.38M sh
FMR
5.89% · 3.32M sh
T. Rowe Price Group, Inc.
5.61% · 3.16M sh
United Capital Financial Advisors
4.94% · 2.79M sh
Vanguard Capital Management, LLC
4.87% · 2.75M sh
Roy T Eddleman Living Trust Uad 08/17/2000
4.79% · 2.71M sh
Vanguard Portfolio Management, LLC
4.10% · 2.31M sh
Maverick Capital, Ltd.
3.52% · 1.98M sh
State Street Global Advisors
3.19% · 1.80M sh
MFS Investment Management
2.87% · 1.62M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 22 sells
| Name | Role | Stake |
|---|---|---|
| Karen Dawes | Independent Chairperson of the Board | 0.16% |
| Glenn Muir | Independent Director | 0.07% |
| Ralf Kuriyel | Officer | 0.02% |
| James Bylund | Chief Operating Officer | 0.01% |
| Martin Madaus | Independent Director | 0.01% |
| Carrie Eglinton Manner | Independent Director | 0.01% |
| Nicholas Barthelemy | Independent Director | 0.01% |
| Rohin Mhatre | Independent Director | 0.01% |
| Jason Garland | Chief Financial Officer | 0.01% |
| Konstantin Konstantinov | Member of Scientific Advisory Board & Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-04 | Olivier Loeillot | President & Chief Commercial Officer | Intent to Sell (Form 144) | -4,202 | $190.00 |
| 2026-10-04 | Olivier Loeillot | President & Chief Commercial Officer | Intent to Sell (Form 144) | -1,333 | $178.75 |
| 2026-10-01 | Olivier Loeillot | President & Chief Commercial Officer | Sale to Issuer | -1,248 | $181.70 |
| 2026-09-24 | Jason Garland | Chief Financial Officer | Sale to Issuer | -421 | $189.68 |
| 2026-09-23 | Olivier Loeillot | President & Chief Commercial Officer | Derivative Exercise and Sale | -12,946 | $154.96–190.00 |
| 2026-09-20 | Olivier Loeillot | President & Chief Commercial Officer | Derivative Exercise and Sale | -5,426 | $141.79–180.00 |
| 2026-09-03 | Olivier Loeillot | President & Chief Commercial Officer | Automatic Disposition | -3,035 | $165.90 |
| 2026-09-02 | Olivier Loeillot | President & Chief Commercial Officer | Sale to Issuer | -2,842 | $169.61 |
| 2026-08-31 | Violetta Hughes | Chief Accounting Officer | Sale to Issuer | -277 | $170.02 |
| 2026-08-19 | Olivier Loeillot | President & Chief Commercial Officer | Derivative Exercise and Sale | -5,426 | $141.79–180.00 |
| 2026-07-15 | Jason Garland | Chief Financial Officer | Automatic Disposition | -530 | $150.00 |
| 2026-06-24 | Jason Garland | Chief Financial Officer | Automatic Disposition | -733 | $145.00 |
| 2026-05-13 | Glenn Muir | Independent Director | Other Acquisition | +995 | -- |
| 2026-05-13 | Glenn Muir | Independent Director | Other Derivative Acquisition | +2,239 | $103.38 |
| 2026-05-13 | Martin Madaus | Independent Director | Other Acquisition | +995 | -- |
| 2026-05-13 | Martin Madaus | Independent Director | Other Derivative Acquisition | +2,239 | $103.38 |
| 2026-05-13 | Karen Dawes | Independent Chairperson of the Board | Other Acquisition | +995 | -- |
| 2026-05-13 | Karen Dawes | Independent Chairperson of the Board | Other Derivative Acquisition | +2,239 | $103.38 |
| 2026-05-13 | Margaret Pax | Director | Other Acquisition | +995 | -- |
| 2026-05-13 | Margaret Pax | Director | Other Derivative Acquisition | +2,239 | $103.38 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:13:50 · For reference only, not investment advice and not tailored to your situation.